Riskpilot← Back to searchSign inGet full accessInnZ Medical AB
ABActiveOrg 5567663157Backegårdsvägen 2Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20087 employees
Revenue 2024
SEK 87,3M
+8% vs 2023
EBITDA margin
8.7%
+115% vs 2023
Equity ratio
22.5%
Financial strength
Net profit 2024
SEK 4,5M
+105% vs 2023
| Revenue | SEK 87,3M | +8% |
| EBITDA | SEK 7,6M | +115% |
| Net profit | SEK 4,5M | +105% |
| Total assets | SEK 39,7M | -14% |
| Equity | SEK 8,9M | +101% |
| Employees | 7 | — |
Legal name
InnZ Medical AB
Org number
5567663157
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
24 september 2008
Share capital
SEK 100 000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva försäljning och service av instrument och utrustning till optiker och ögonläkare samt bedriva e-handel med ögon- och hudvårdsprodukter med särskild inriktning mot ögonhälsa, inklusive tillhörande tillbehör och relaterade produkter, jämte därmed förenlig verksamhet.
Address
Backegårdsvägen 2
Phone
+46522266065
Email
dbansal@innz.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 43 948 | 67 563 | 78 783 | 80 876 | 87 327 |
| Staff expenses | — | — | −5 692 | −6 235 | −6 811 |
| EBITDA | 1 527 | 2 901 | 3 188 | 3 516 | 7 565 |
| Depreciation & amort. | −26 | −51 | −77 | −104 | −95 |
| EBIT | 1 501 | 2 850 | 3 111 | 3 412 | 7 470 |
| Net financials | 352 | −181 | −91 | −33 | −500 |
| Profit before tax | 1 363 | 1 980 | 2 220 | 2 801 | 5 749 |
| Tax | −317 | −431 | −507 | −618 | −1 268 |
| Net profit | 1 046 | 1 549 | 1 713 | 2 182 | 4 482 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 26 580 | 28 123 | 27 776 | 46 084 | 39 722 |
| Equity | 4 585 | 6 134 | 2 272 | 4 455 | 8 937 |
| Long-term debt | 5 238 | 3 569 | 5 596 | 4 809 | 4 947 |
| Short-term debt | 14 191 | 15 163 | 15 852 | 32 651 | 20 448 |
| Total debt | 19 429 | 18 732 | 21 448 | 37 460 | 25 395 |
EBITDA margin
8.7%
This company
15.8%
Market median
-45% vs market
20202024
Equity ratio
22.5%
This company
38.2%
Market median
-41% vs market
20202024
Return on equity
50.1%
This company
18.4%
Market median
+172% vs market
20202024
Net profit margin
5.1%
This company
8.1%
Market median
-37% vs market
20202024
Asset turnover
2.20×
This company
1.12×
Market median
+96% vs market
20202024
Debt / equity
3.44×
This company
0.62×
Market median
-455% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
DB Chief Executive Officer | Chief Executive Officer | 2022 |
BS Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bansal Group AB
InnZ Medical AB Board members of InnZ Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dheeraj Bansal | Chief Executive Officer | 0 companies |
| Bo Stefan Carlsson | Audit | 0 companies |
| Monika Duchna | Deputy Board Member | 0 companies |